Alaunos Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
Alaunos Therapeutics, Inc. (TCRT) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of 0.00% for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-01.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2021-03-01
- Alaunos Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2019 was 0.00%.
- Alaunos Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2018 was -1.00%.
- Alaunos Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2017 was -2.00%.
- Alaunos Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2016 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2019-12-31 | 0.00% 10-K · filed 2021-03-01 | -1.00% 10-K · filed 2020-03-02 |
| 2018-12-31 | -1.00% 10-K · filed 2021-03-01 | -2.00% 10-K · filed 2019-03-05 |
| 2017-12-31 | -2.00% 10-K · filed 2021-03-01 | -3.00% 10-K · filed 2018-03-01 |
| 2016-12-31 | 0.00% 10-K · filed 2019-03-05 | |
| 2015-12-31 | 0.00% 10-K · filed 2018-03-01 | |
| 2014-12-31 | -4.00% 10-K · filed 2017-02-16 | |
| 2013-12-31 | 1.00% 10-K · filed 2016-02-24 | 0.00% 10-K · filed 2014-03-03 |
| 2012-12-31 | 2.00% 10-K · filed 2015-02-26 | 0.00% 10-K · filed 2013-03-18 |
| 2011-12-31 | 0.00% 10-K · filed 2014-03-03 | |
| 2010-12-31 | 1.50% 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |